Correvio Pharma

YTD

ALL

Why Robinhood?

You can watch CORV and buy or sell other stocks, ETFs, and their options commission-free!

About CORV

Cardiome Pharma Corp. is a specialty biopharmaceutical company dedicated to the discovery, development and commercialization of new therapies that will improve the health of patients suffering from heart disease around the world. Cardiome has one marketed product, BRINAVESSTM (vernakalant IV), approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.

CEO

Mark H. N. Corrigan, MD

CEOMark H. N. Corrigan, MD

Employees

—

Employees—

Headquarters

Toronto, Ontario

HeadquartersToronto, Ontario

Founded

1986

Founded1986

Employees

—

Employees—

CORV Key Statistics

Market cap

27.79M

Market cap27.79M

Price-Earnings ratio

-0.51

Price-Earnings ratio-0.51

Dividend yield

—

Dividend yield—

Average volume

2.43M

Average volume2.43M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$2.79

52 Week high$2.79

52 Week low

$0.21

52 Week low$0.21